Related Experiment Videos

Effect of platelet activating factor antagonist WEB 2086 on the production of TNF from murine peritoneal macrophages

D W Ju1, Q Y Zheng, H B Wang

  • 1Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai.

Insights

Platelet activating factor (PAF) antagonist WEB 2086 significantly inhibited lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF) production in macrophages. This suggests PAF plays a key role in TNF production.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Tumor necrosis factor (TNF) is a key cytokine in inflammatory responses.
  • Platelet activating factor (PAF) is implicated in various inflammatory processes.
  • Understanding the interplay between PAF and TNF is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the effect of the PAF antagonist WEB 2086 on TNF production.
  • To determine the role of PAF in lipopolysaccharide (LPS)-induced TNF release from macrophages.

Main Methods:

  • Murine peritoneal macrophages were primed and stimulated with LPS.
  • The impact of WEB 2086 on TNF production was assessed at different concentrations (10(-6) and 10(-5) mol/L).
  • TNF bioassay was optimized using L-929 cells treated with actinomycin D and sodium fluoride.

Main Results:

  • WEB 2086 significantly inhibited LPS-induced TNF production.
  • Inhibition of TNF release by WEB 2086 was observed starting 4 hours post-stimulation, peaking at 16 hours, and lasting for 22 hours.
  • The optimized bioassay method demonstrated high sensitivity for TNF detection.

Conclusions:

  • PAF antagonist WEB 2086 effectively suppresses TNF production.
  • These findings highlight a significant role for PAF in the regulation of TNF release.
  • The developed bioassay provides a sensitive method for TNF quantification.

Related Concept Videos